Zepbound enters the scene as a potent newcomer, blending the actions of GLP-1 and GIP receptors and has quickly gained a reputation as a leading weight loss drug
PlexusDx patients can work with their treatment team to identify personal metabolic drivers through the Precision Peptide Genetic Test, which maps 14 appetite and energy pathways to guide long-term strategies
Loss of Appetite Although appetite suppression is desired to promote weight loss, it may result in: Skipping meals unintentionally Low energy levels Nutritional deficiencies, if not monitored properly A proper diet becomes essential during GLP-1 treatment
Overall, 9095% of serum DPP-4 activity is related to soluble DPP-4 levels [27,28,29,30,31]
The BUD is determined by the compounding pharmacy based on several factors: The nature of the medication and its stability